Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.
A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.
Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.
One of Hope & Cope’s newest initiatives, the Breast & Bone Health Program, identifies women who have had breast cancer and are at risk for bone fragility.
A new electronic scheduler that manages appointments has dramatically cut the time that patients wait before receiving their first chemotherapy session in the Segal Cancer Centre at the JGH.